Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
04/19/2011 | US7928195 Poly zinc finger proteins with improved linkers |
04/19/2011 | US7928082 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same |
04/19/2011 | US7928081 Combined use of PRAME inhibitors and HDAC inhibitors |
04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
04/19/2011 | US7928071 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
04/19/2011 | US7928069 Crosslinked compounds and methods of making and using thereof |
04/19/2011 | US7928061 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
04/19/2011 | US7927873 Polyamides for nucleic acid delivery |
04/19/2011 | US7927870 DNA vaccine formulations |
04/19/2011 | US7927839 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus |
04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
04/19/2011 | US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
04/19/2011 | US7927803 Human MutY |
04/19/2011 | US7927793 Cell lines and host nucleic acid sequences related to infectious disease |
04/19/2011 | US7927785 Methods for in vitro expansion of hematopoietic stem cells |
04/19/2011 | US7927611 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
04/19/2011 | US7927610 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
04/19/2011 | US7927599 Chondrocyte therapeutic delivery system |
04/19/2011 | CA2478081C Multiple and multivalent dna vaccines in ovo |
04/19/2011 | CA2447703C Methods for proliferating terminal differentiated cells and recombinant vectors therefor |
04/19/2011 | CA2421258C Truncated bard1 protein, and its diagnostic and therapeutic uses |
04/19/2011 | CA2370289C Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
04/19/2011 | CA2226301C Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
04/19/2011 | CA2208245C Purification of a triple helix formation with an immobilized oligonucleotide |
04/14/2011 | WO2011043913A2 Novel cationic lipids with short lipid chains for oligonucleotide delivery |
04/14/2011 | WO2011042556A1 Nucleic acid molecules and methods for exchanging exon(s) by transsplicing |
04/14/2011 | WO2011020023A3 Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus |
04/14/2011 | WO2010140834A9 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof |
04/14/2011 | US20110088106 Compositions and methods for mediating cell cycle progression |
04/14/2011 | US20110086905 Pseudocomplementary Oligonucleotides for Targeted Gene Therapy |
04/14/2011 | US20110086090 Vectors Containing the Max Gene |
04/14/2011 | US20110086072 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
04/14/2011 | US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
04/14/2011 | US20110086040 Method of treating hemolytic disease |
04/14/2011 | US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon |
04/14/2011 | US20110083987 Methods and compositions for tissue regeneration |
04/14/2011 | CA2776834A1 Nucleic acid molecules and methods for exchanging exon(s) by transsplicing |
04/14/2011 | CA2776748A1 Use of pedf in an encapsulated cell-based delivery system |
04/13/2011 | EP2308996A1 Therapeutic and diagnostic applications based on the role of the CXCR-4 and SDF-1 genes in tumourigenesis |
04/13/2011 | EP2308987A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
04/13/2011 | EP2308981A1 Streptococcal C5a peptidase vaccine |
04/13/2011 | EP2308515A1 Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors |
04/13/2011 | EP2308502A1 Method to induce neovascular formation and tissue regeneration |
04/13/2011 | EP2308473A1 Pharmaceutical composition containing surface-coated microparticles |
04/13/2011 | EP2307575A1 Unprocessed rolling circle amplification product |
04/13/2011 | EP2307542A1 Method for treating or preventing radiation damage by in vivo gene therapy |
04/13/2011 | EP2306978A2 Compositions for the in vivo delivery of rnai agents |
04/13/2011 | EP2306929A1 Medical devices and methods for delivery of nucleic acids |
04/13/2011 | EP1543020B1 Codon optimized synthetic plasmids |
04/13/2011 | EP1458749B1 Bone polypeptide-1 |
04/13/2011 | EP1412485B1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
04/13/2011 | EP0957941B1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
04/13/2011 | CN1910456B Marker for neuromyelitis optica |
04/13/2011 | CN1379820B Lentiviral vectors for preparation of immunotherapeutical compositions |
04/13/2011 | CN102014948A Modulation of adenoviral tropism |
04/13/2011 | CN102010863A miRNA for expressing sex difference of Ascaris suum, corresponding prosoma, antisense oligonucleotide and application thereof |
04/13/2011 | CN102010463A Consensus/ancestral immunogens |
04/13/2011 | CN102008735A Small molecular DNA vaccine and preparation method thereof |
04/13/2011 | CN102008724A Method and reagent for inhibiting hepatocellular carcinoma |
04/13/2011 | CN102008718A Application of SIRT (Silent Mating Type Information Regulation 2 Homolog 1) to prepare medicine used for regulating down the expression of cyclin D1 |
04/13/2011 | CN102008503A Hematopoietic cells from human embryonic stem cells |
04/13/2011 | CN102008441A Endoglin antibody coupled liposome as well as preparation method and application thereof |
04/13/2011 | CN101633923B Long non-coding RNA sequence relevant to human melanoma cells and application thereof |
04/13/2011 | CN101606948B Application of small interfering RNA in preparing medicament for treating colon cancer |
04/12/2011 | US7923560 Delivery of immune response modifier compounds |
04/12/2011 | US7923548 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
04/12/2011 | US7923547 for antisense therapy |
04/12/2011 | US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
04/12/2011 | US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 |
04/12/2011 | US7923509 Drug delivery compositions and medical devices containing block copolymer |
04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
04/12/2011 | US7923250 Transfection with nucleic acid; insertion |
04/12/2011 | US7923243 Expression vector comprising glucose regulated protein 78 (grp78) stress-responsive promoter and endoplasmic reticulum stress elements for use in tissue specific heterologous gene expression for treatment and prevention of cell proliferative and inflammatory disorders |
04/12/2011 | US7923017 Modified Vaccinia Ankara virus variant |
04/12/2011 | US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
04/12/2011 | US7923007 Brain tissue damage therapies |
04/12/2011 | CA2414241C Polymeric micelle compositions |
04/12/2011 | CA2388363C Dna polymerase lambda and uses thereof |
04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
04/12/2011 | CA2326719C Use of triplex structure dna sequences for transferring nucleotide sequences |
04/07/2011 | WO2011041502A1 Aav vectors expressing sec1o for treating kidney damage |
04/07/2011 | WO2011041093A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
04/07/2011 | WO2011040887A1 A nuclear receptor and mutant thereof and the use of the same in the reprogramming of cells |
04/07/2011 | WO2011040613A1 Therapeutic agent for tumor |
04/07/2011 | WO2011040597A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
04/07/2011 | WO2011040503A1 Method for recovery of sensitivity to anti-cancer agents in cancer cell that acquires resistance to anti-cancer agents |
04/07/2011 | WO2011040428A1 Anti-tumor agent and method for screening for same |
04/07/2011 | WO2011040220A1 Composition for treatment of pancreatic cancer |
04/07/2011 | WO2011002077A8 TNF-α GENE THERAPY AGENT CONTAINED IN POLYMERIC MICELLE |
04/07/2011 | WO2010131916A3 Sirna conjugate and preparation method thereof |
04/07/2011 | WO2010099301A3 Piggybac transposon variants and methods of use |
04/07/2011 | WO2010043630A3 A delivery system for rna |
04/07/2011 | US20110082482 Materials and Methods for Nerve Repair |
04/07/2011 | US20110082191 Method for treating or preventing radiation damage by in vivo gene therapy |
04/07/2011 | US20110082095 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |
04/07/2011 | US20110081360 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
04/07/2011 | US20110081359 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
04/07/2011 | US20110081332 Treatment of non-alcoholic steatotic hepatitis (nash) |
04/07/2011 | US20110079528 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |